Related Experiment Video
Updated: Jan 24, 2026

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)
Published on: June 12, 2017
Abstract:
Since 2017, the NCI-COG Pediatric MATCH trial has been investigating whether matching patients to targeted therapies based on genomic alterations in their tumors can be applied to kids. Interim results from the trial indicate that children and adolescents with a wide range of cancers can be successfully screened for tumor mutations and prescribed a targeted therapy.
Insights
The National Cancer Institute-Children's Oncology Group Pediatric MATCH trial shows that matching pediatric cancer patients to targeted therapies based on tumor genomic alterations is feasible. Interim findings confirm successful screening and targeted therapy prescription for diverse childhood cancers.
Area of Science:
- Oncology
- Genomics
- Pediatric Medicine
Background:
- The NCI-COG Pediatric MATCH trial, initiated in 2017, explores targeted therapy efficacy in pediatric cancers.
- Genomic alterations in tumors are increasingly recognized as drivers of cancer development.
Related Concept Videos
Sign Test for Matched Pairs
To conduct the sign test, we first calculate the differences in...
Wilcoxon Signed-Ranks Test for Matched Pairs
Gene Therapy
Group Therapy
Drug Dosing: Infants and Children
Psychodynamic Therapy

